Metabolic disturbances in shock, and the role of ATP-MgCl2 and sex steroids

Medical Principles and Practice

Volumn 13, Issue 1, 2004, Pages 2-9

  Jarrar, Doraid ^a   Wang, Ping ^a   Chaudry, Irshad H ^a  

^a Kentucky   (United States)

Author keywords

Adenosine triphosphate; Cell metabolism; Estradiol; Gender; Hemorrhage; Hypoxia; Low flow conditions; Oxygen; Trauma

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; CATECHOLAMINE; CYTOKINE; ESTRADIOL; FLUTAMIDE; HORMONE RECEPTOR BLOCKING AGENT; SEX HORMONE; TESTOSTERONE; TRANSCRIPTION FACTOR;

AEROBIC METABOLISM; BLOOD FLOW; BLOOD OXYGEN TENSION; BLOOD VOLUME; BREATHING RATE; CASTRATION; CATECHOLAMINE RELEASE; CELL FUNCTION; CELL METABOLISM; CYTOKINE PRODUCTION; DRUG EFFECT; HEART OUTPUT; HEMORRHAGIC SHOCK; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPOVOLEMIC SHOCK; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE SYSTEM; METABOLIC DISORDER; MICROCIRCULATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SYMPATHETIC TONE; TISSUE INJURY; TREATMENT OUTCOME; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; GONADAL STEROID HORMONES; HUMANS; SHOCK, HEMORRHAGIC; SHOCK, TRAUMATIC;

EID: 0345600145     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074043     Document Type: Review

References (133)

1. Leach RM, Treacher DF: The pulmonary physician in critical care. 2. Oxygen delivery and consumption in the critically ill. Thorax 2002;57:170-177.
2. Fink MP: Cytopathic hypoxia: Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001;17:219-237.
3. Hierholzer C, Harbrecht BG, Billiar TR, Tweardy DJ: Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Arch Orthop Trauma Surg 2001;121:219-222.
4. Luchette FA, Jenkins WA, Friend LA, Su C, Fischer JE, James JH: Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002;52:415-419.
5. Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F: Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock 2000;14:35-40.
6. 2 as early warning of tissue hypoxia and hemodynamic shock in critically ill emergency patients. Crit Care Med 2000;28:2248-2253.
7. Johnson KB, Charya RV, Wiesmann WP, Pearce FJ: Plasma and tissue histamine changes during hemorrhagic shock in the rat. Shock 1995;3:343-349.
8. Kaibori M, Inoue T, Tu W, Oda M, Kwon AH, Kamiyama Y, Okumura T: FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Life Sci 2001;69:17-26.
9. 2 after trauma-hemorrhage and resuscitation restores the depressed cardiac performance. J Surg Res 1997;69:159-165.
10. 2 restores depressed endothelial cell function after hemorrhagic shock and resuscitation. Am J Physiol 1995;268:H1390-H1396.
11. 2 administration normalizes macrophage cAMP and beta-adrenergic receptors after hemorrhage and resuscitation. Am J Physiol 1994;267:G52-G58.
12. 2-purinoceptor binding capacity. Am J Physiol 1994;266:R1810-R1815.
13. Cairns CB: Rude unhinging of the machinery of life: Metabolic approaches to hemorrhagic shock. Curr Opin Crit Care 2001;7:437-443.
14. Hierholzer C, Billiar TR: Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001;386:302-308.
15. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, Hoppeler H: Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J Appl Physiol 2001;91:173-182.
16. Rivers EP, Ander DS, Powell D: Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001;7:204-211.
17. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV: Outcome after hemorrhagic shock in trauma patients. J Trauma 1998;45:545-549.
18. Hutter J, Habler O, Kleen M, Tiede M, Podtschaske A, Kemming G, Corso C, Batra S, Keipert P, Faithfull S, Messmer K: Effect of acute normovolemic hemodilution on distribution of blood flow and tissue oxygenation in dog skeletal muscle. J Appl Physiol 1999;86:860-866.
19. Habler OP, Messmer KF: The physiology of oxygen transport. Transfus Sci 1997;18:425-435.
20. Kleen M, Habler O, Hutter J, Podtschaske A, Tiede M, Kemming G, Corso C, Batra S, Keipert P, Faithfull S, Messmer K: Effects of hemodilution on splanchnic perfusion and hepatorenal function. I. Splanchnic perfusion. Eur J Med Res 1997;2:413-418.
21. Habler O, Kleen M, Hutter J, Podtschaske A, Tiede M, Kemming G, Corso C, Batra S, Keipert P, Faithfull S, Messmer K: Effects of hemodilution on splanchnic perfusion and hepatorenal function. II. Renal perfusion and hepatorenal function. Eur J Med Res 1997;2:419-424.
22. Grange RW, Meeson A, Chin E, Lau KS, Stull JT, Shelton JM, Williams RS, Garry DJ: Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice. Am J Physiol Cell Physiol 2001;281:C1487-C1494.
23. Barker JE, Knight KR, Romeo R, Hurley JV, Morrison WA, Stewart AG: Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle. J Pathol 2001;194:109-115.
24. Ikeda Y, Young LH, Scalia R, Lefer AM: Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism. Methods Find Exp Clin Pharmacol 2000;22:563-571.
25. 2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg 1999;68:1920-1923.
26. Lefer AM: Endotoxin, cytokines, and nitric oxide in shock. Shock 1994;1:79-80.
27. Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, Eisenmenger S, Messmer K, Krombach F: Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999;94:3829-3838.
28. Thorlacius H, Vollmar B, Westermann S, Torkvist L, Menger MD: Effects of local cooling on microvascular hemodynamics and leukocyte adhesion in the striated muscle of hamsters. J Trauma 1998;45:715-719.
29. Menger MD, Rucker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion: On the mechanisms of capillary 'no-reflow'. Shock 1997;8:2-7.
30. Becker M, Menger MD, Lehr HA: Heparin-released superoxide dismutase inhibits post-ischemic leukocyte adhesion to venular endothelium. Am J Physiol 1994;267:H925-H930.
31. Menger MD, Kerger H, Geisweid A, Leu AJ, Hecht R, Nolte D, Messmer K: Leukocyte-endothelium interaction in the microvasculature of postischemic striated muscle. Adv Exp Med Biol 1994;361:541-545.
32. Menger MD, Vollmar B: In vivo analysis of microvascular reperfusion injury in striated muscle and skin. Microsurgery 1994;15:383-389.
33. Menger MD, Pelikan S, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of 'reflow paradox'. Am J Physiol 1992;263:H1901-H1906.
34. Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C mice. Am J Physiol 1994;267:H1320-H1328.
35. Kadambi A, Skalak TC: Role of leukocytes and tissue-derived oxidants in short-term skeletal muscle ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2000;278:H435-H443.
36. Waxman K: Shock: Ischemia, reperfusion, and inflammation. New Horiz 1996;4:153-160.
37. Nolte D, Lehr HA, Messmer K: Adenosine inhibits postischemic leukocyte-endothelium interaction in postcapillary venules of the hamster. Am J Physiol 1991;261:H651-H655.
38. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K: Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991;87:2036-2041.
39. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Costantino G, Caputi AP, Thiemermann C: Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock 2000;14:150-156.
40. Akgur FM, Brown MF, Zibari GB, McDonald JC, Epstein CJ, Ross CR, Granger DN: Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 2000;279:H791-H797.
41. Kyriakides C, Woodcock SA, Wang Y, Favuzza J, Austen WG Jr, Kobzik L, Moore FD Jr, Valeri RC, Shepro D, Hechtman HB: Soluble P-selectin moderates complement-dependent reperfusion injury of ischemic skeletal muscle. Am J Physiol Cell Physiol 2000;279:C520-C528.
42. Tailor A, Granger DN: Role of adhesion molecules in vascular regulation and damage. Curr Hypertens Rep 2000;2:78-83.
43. Jaeschke H: Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreas Surg 1998;5:402-408.
44. Weiser MR, Gibbs SA, Valeri CR, Shepro D, Hechtman HB: Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury. Shock 1996;5:402-407.
45. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995;57:368-374.
46. Razandi M, Pedram A, Levin ER: Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 2000;275:38540-38546.
47. Wu G, Meininger CJ: Arginine nutrition and cardiovascular function. J Nutr 2000;130:2626-2629.
48. Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255-266.
49. Wang P, Ba ZF, Chaudry IH: Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol 1995;269:R988-R994.
50. Jarrar D, Wang P, Chaudry IH: Hepatocellular dysfunction: 'Basic considerations'; in Holzheimer RG, Mannick JA (eds): Surgical Treatment Evidence-Based and Problem-Oriented. Munich, Zuckschwerdt, 2001, pp 763-767.
51. Linden J: Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-787.
52. Chaudry IH: Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983;245:R117-R134.
53. Chaudry IH, Harkema JM, Dean RE: Alterations in energy production: A manifestation of cell injury; in Bihari DJ, Cerra FB (eds): New Horizons: Multiple Organ Failure. Fullerton, Society of Critical Care Medicine, 1989, pp 277-296.
54. 2 treatment. Am J Physiol 1985;248:H804-H811.
55. 2 and liver blood flow following shock and ischemia. Prog Clin Biol Res 1989;299:19-31.
56. Uhlmann D, Uhlmann S, Spiegel HU: Endothelin/nitric oxide balance influences hepatic ischemia-reperfusion injury. J Cardiovasc Pharmacol 2000;36:S212-S214.
57. Traber DL: Nitric oxide synthase and tissue injury. Shock 2000;14:243-244.
58. Kozlov AV, Sobhian B, Duvigneau C, Gemeiner M, Nohl H, Redl H, Bahrami S: Organ specific formation of nitrosyl complexes under intestinal ischemia/reperfusion in rats involves NOS-independent mechanism(s). Shock 2001;15:366-371.
59. Kim H, Hwan KK: Role of nitric oxide and mucus in ischemia/reperfusion- induced gastric mucosal injury in rats. Pharmacology 2001;62:200-207.
60. Geller DA, Chia SH, Takahashi Y, Yagnik GP, Tsoulfas G, Murase N: Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. JPEN J Parenter Enteral Nutr 2001;25:142-147.
61. Zhou M, Wang P, Chaudry IH: Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1997;1335:182-190.
62. Wang P, Ba ZF, Stepp KJ, Chaudry IH: Pentoxifylline attenuates the depressed endothelial cell function and vascular muscle contractility following trauma and hemorrhagic shock. J Trauma 1995;39:121-126.
63. Wang P, Ba ZF, Chaudry IH: Nitric oxide: To block or enhance its production during sepsis? Arch Surg 1994;129:1137-1142.
64. McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C: Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 2001;15:171-186.
65. Jarrar D, Wang P, Song GY, Cioffi WG, Bland KI, Chaudry IH: Inhibition of tyrosine kinase signaling after trauma-hemorrhage: A novel approach for improving organ function and decreasing susceptibility to subsequent sepsis. Ann Surg 2000;231:399-407.
66. Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, Fassler R, Ruth P, Krombach F, Hofmann F: Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′-monophosphate kinase I. J Exp Med 1999;189:1255-1264.
67. Tacchini L, Fusar-Poli D, Bernelli-Zazzera A: Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochem Pharmacol 2002;63:139-148.
68. Baek SH, Lee UY, Park EM, Han MY, Lee YS, Park YM: Role of protein kinase C delta in transmitting hypoxia signal to HSF and HIF-1. J Cell Physiol 2001;188:223-235.
69. Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG, Wenger RH: Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J Biol Chem 2002;277:9262-9267.
70. Qian J, Ramroop K, McLeod A, Bandari P, Livingston DH, Harrison JS, Rameshwar P: Induction of hypoxia-inducible factor-1alpha and activation of caspase-3 in hypoxia-reoxygenated bone marrow stroma is negatively regulated by the delayed production of substance P. J Immunol 2001;167:4600-4608.
71. Suzuki H, Tomida A, Tsuruo T: Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 2001;20:5779-5788.
72. Cornelussen RN, Gupta S, Knowlton AA: Regulation of prostaglandin A1-induced heat shock protein expression in isolated cardiomyocytes. J Mol Cell Cardiol 2001;33:1447-1454.
73. Hierholzer C, Kelly E, Lyons V, Roedling E, Davies P, Billiar TR, Tweardy DJ: G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol 1998;63:169-174.
74. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ: Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 2001;81:1461-1497.
75. Park KM, Chen A, Bonventre JV: Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:11870-11876.
76. Dawn B, Xuan YT, Marian M, Flaherty MP, Murphree SS, Smith TL, Bolli R, Jones WK: Cardiac-specific abrogation of NF-kappa B activation in mice by transdominant expression of a mutant I kappa B alpha. J Mol Cell Cardiol 2001;33:161-173.
77. Okubo S, Bernardo NL, Elliott GT, Hess ML, Kukreja RC: Tyrosine kinase signaling in action potential shortening and expression of HSP72 in late preconditioning. Am J Physiol Heart Circ Physiol 2000;279:H2269-H2276.
78. Dana A, Skarli M, Papakrivopoulou J, Yellon DM: Adenosine A (1) receptor induced delayed preconditioning in rabbits: Induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 2000;86:989-997.
79. Morgan EN, Boyle EM Jr, Yun W, Griscavage-Ennis JM, Farr AL, Canty TG Jr, Pohlman TH, Verrier ED: An essential role for NF-kappaB in the cardioadaptive response to ischemia. Ann Thorac Surg 1999;68:377-382.
80. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK: Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996;396:233-237.
81. Chaudry IH, Sayeed MM, Baue AE: Effect of adenosine triphosphate- magnesium chloride administration in shock. Surgery 1974;75:220-227.
82. Chaudry IH: The effect of ATP on survival in intestinal ischemia shock, hemorrhagic shock, and endotoxin shock in rats. Circ Shock 1982;9:629-631.
83. Chaudry IH, Hirasawa H, Baue AE: Effect of adenosine triphosphate- glucose administration following sepsis. J Surg Res 1980;29:348-356.
84. 2 added to resuscitation improves survival in an experimental model of hemorrhagic shock. Resuscitation 1994;28:253-257.
85. 2-glucose administration during hemorrhagic shock on cardiovascular function, metabolism, and survival. Adv Shock Res 1980;3:153-166.
86. Filkins JP, Buchanan BJ: Protection against endotoxin shock and impaired glucose homeostasis with ATP. Circ Shock 1977;43:253-258.
87. 2 therapy in sepsis. Am J Emerg Med 1984;2:38-44.
88. 2. Adv Shock Res 1982;8:177-186.
89. 2 produces sustained improvement in hepatic mitochondrial function and blood flow after hepatic ischemia. J Surg Res 1984;37:226-234.
90. 2. Am J Physiol 1984;246:R799-R804.
91. 2 following hepatic ischemia. Am J Physiol 1983;244:R695-702.
92. 2 following warm ischemia. Am J Physiol 1984;247:R1047-R1053.
93. Chaudry IH: The use of ATP following shock and ischemia. Ann NY Acad Sci 1990;603:130-141.
94. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994;90:1287-1293.
95. 2 on hepatic cell permeability and metabolism following hemorrhagic shock. Surgery 1981;90:328-335.
96. 2 pretreatment. Am J Physiol 1988;254:H702-H708.
97. 2 administration for postischemic acute renal failure. Clin Exp Dial Apheresis 1983;7:37-47.
98. Ali A, Goldberg RN, Suguihara C, Huang J, Martinez O, Feuer W, Bancalari E: Effects of ATP-magnesium chloride on the cardiopulmonary manifestations of group B streptococcal sepsis in the piglet. Pediatr Res 1996;39:609-615.
99. 2 during hyperdynamic porcine endotoxemia: Effects on hepato-splanchnic oxygen exchange and metabolism. Crit Care Med 2002;30:1826-1833.
100. Paidas CN, Dudgeon DL, Haller JA, Clemens MG: Adenosine triphosphate: A potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg 1988;23:1154-1160.
101. Paidas CN, Dudgeon DL, Haller JA, Clemens MG: Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension: Comparison of dose dependence in pulmonary and renal circulations. J Surg Res 1989;46:374-379.
102. Gaba SJ, Bourgouin KD, Dujols P, Michel FB, Prefaut C: Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: A pulmonary vasoregulator? Am Rev Respir Dis 1986;134:1140-1144.
103. 2 for postischemic acute renal failure (ARF) (abstract). Circ Shock 1985;13:66.
104. 2 (abstract). Circ Shock 1989;27:361.
105. Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, Froba G: Adenosine triphosphate-magnesium chloride: Relevance for intensive care. Intensive Care Med 2003;29:10-18.
106. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH: Improved immune responses in females as opposed to decreased immune responses in males following hemorrhagic shock and resuscitation. Cytokine 1996;8:853-863.
107. Angele MK, Schwacha MG, Ayala A, Chaudry IH: Effect of gender and sex hormones on immune responses following shock. Shock 2000;14:81-90.
108. Wichmann MW, Ayala A, Chaudry IH: Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 1997;273:C1335-C1340.
109. Remmers DE, Cioffi WG, Bland KI, Wang P, Angele MK, Chaudry IH: Testosterone: The crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 1998;227:790-799.
110. Ba ZF, Wang P, Koo DJ, Ornan DA, Bland KI, Chaudry IH: Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock. Arch Surg 2001;136:1158-1163.
111. Wichmann MW, Angele MK, Ayala A, Cioffi WG, Chaudry IH: Flutamide: A novel agent for restoring the depressed cell-mediated immunity following soft-tissue trauma and hemorrhagic shock. Shock 1997;8:242-248.
112. Ba ZF, Wang P, Kuebler JF, Rue LW III, Bland KI, Chaudry IH: Flutamide induces relaxation in large and small blood vessels. Arch Surg 2002;137:1180-1186.
113. Ba ZF, Wang P, Koo DJ, Ornan DA, Bland KI, Chaudry IH: Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock. Arch Surg 2001;136:1158-1163.
114. Nolan JP: Protective action of oestrogen against the lethal effect of endotoxin in the rat. Nature 1967;213:201-202.
115. Ma XL, Gao F, Chen J, et al: Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats. Am J Physiol 2001;280:H876-H884.
116. Palacios B, Pang CC: Protective effects of ethynylestradiol on the hemodynamic changes induced by lipopolysaccharide in anesthetized rats. J Cardiovasc Pharmacol 1998;31:479-483.
117. Eckhoff DE, Bilbao G, Frenette L, Thompson A, Contreras JL: 17-Beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002;132:302-309.
118. Yokoyama Y, Schwacha MG, Bland KI, Chaudry IH: Effect of estradiol administration on splanchnic perfusion after trauma-hemorrhage and sepsis. Curr Opin Crit Care 2003;9:137-142.
119. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
120. Knöferl M, Jarrar D, Angele MK, Ayala A, Schwacha MG, Bland KI, Chaudry IH: 17β-Estradiol normalizes immune responses in ovariectomized females after trauma-hemorrhage. Am J Physiol Cell Physiol 2001;281:C1131-C1138.
121. Mizushima Y, Wang P, Jarrar D, Cioffi WG, Bland KI, Chaudry IH: Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in males. Ann Surg 2000;232:673-679.
122. Kuebler JF, Jarrar D, Toth B, Bland KI, Rue L III, Wang P, Chaudry IH: Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 2002;137:74-79.
123. Caruso JM, Xu DZ, Lu Q, Dayal SD, Deitch EA: The female gender protects against pulmonary injury after trauma hemorrhagic shock. Surg Infect (Larchmt) 2001;2:231-240.
124. Trentzsch H, Stewart D, De Maio A: Genetic background conditions the effect of sex steroids on the inflammatory response during endotoxic shock. Crit Care Med 2003;31:232-236.
125. Knöferl M, Angele MK, Schwacha MG, Bland KI, Chaudry IH: Preservation of splenic immune functions following trauma-hemorrhage by female sex hormones. Crit Care Med 2002;30:888-893.
126. Knöferl M, Angele MK, Diodato MD, Schwacha MG, Ayala A, Cioffi WG, Bland KI, Chaudry IH: Female sex hormones regulate macrophage function following trauma-hemorrhage and prevent increased mortality from subsequent sepsis. Ann Surg 2002;235:105-112.
127. Yokoyama Y, Kuebler JF, Matsutani T, Schwacha MG, Bland KI, Chaudry IH: Mechanism of the salutary effects of 17β-estradiol following trauma-hemorrhage: Direct down regulation of Kupffer cell proinflammatory cytokine production. Cytokine 2003;21:91-97.
128. Jarrar D, Wang P, Knoferl MW, Kuebler JF, Cioffi WG, Bland KI, Chaudry IH: Insight into the mechanism by which estradiol improves organ functions after trauma-hemorrhage. Surgery 2000;128:246-252.
129. Samy TSA, Knöferl M, Schwacha MG, Bland KI, Chaudry IH: Divergent immune responses in male and female mice following trauma-hemorrhage: Dimorphic alterations in T lymphocyte steroidogenic enzyme activities. Endocrinology 2001;142:3519-3529.
130. Zheng R, Samy TSA, Schneider CP, Rue LW, Bland KI, Chaudry IH: Decreased 5′-dihydrotestosterone catabolism suppress T lymphocyte functions in males following trauma-hemorrhage. Am J Physiol Cell Physiol 2002;282:C1332-C1338.
131. Samy TS, Schwacha MG, Cioffi WG, Bland KI, Chaudry IH: Androgen and estrogen receptors in splenic T lymphocytes: Effects of flutamide and trauma-hemorrhage. Shock 2000;14:465-470.
132. Samy TSA, Zheng R, Matsutani T, Rue LW, Bland KI, Chaudry IH: Mechanism for normal splenic T lymphocyte functions in proestrus females after trauma: Enhanced local synthesis of 17β-estradiol. Am J Physiol, in press.
133. Yukihiro Yokoyama Y, Schwacha MG, Bland KI, Chaudry IH: Effect of estradiol administration on splanchnic perfusion following trauma-hemorrhage. Curr Opin Crit Care 2003;2:137-142.